Transcriptomics

Dataset Information

0

Gene expression profiling in primary human skeletal myotubes with small molecule inhibitors of lipid accumulation


ABSTRACT: The development of insulin resistance is strongly associated with accumulation of intracellular lipid in tissues outside of adipose including skeletal muscle, liver and heart. In obese humans, intramyocellular lipid (IMCL) is negatively correlated with whole body insulin sensitivity. The skeletal myocyte imports fatty acids (FA) into the cell from circulating free fatty acids or lipoprotein particles such as VLDL, to support energy production. Once transported into the cell, FAs are oxidized for ATP production, used to build membranes, or stored as triglyceride. However, in the long term, increased delivery of fatty acids can exceed mitochondrial oxidative capacity and set the stage for a vicious cycle of cellular lipotoxicity. We have recently identified a novel small molecule inhibitor of lipid accumulation in skeletal mycytes termed SBI-477. Microarray transcriptomics was performed in primary human skeletal myotubes following oleate loading and treatment with SBI-477. This was also compared to A922500, a diacylglycerol transferase 1 (DGAT1) inhibitor. SBI-477 treatment reversed many of the transcriptomic effects of oleate loading in these cells but also produced a transcriptomic profile distinct from the DGAT1 inhibitor.

ORGANISM(S): Homo sapiens

PROVIDER: GSE77212 | GEO | 2016/08/08

SECONDARY ACCESSION(S): PRJNA309711

REPOSITORIES: GEO

Dataset's files

Source:
Action DRS
Other
Items per page:
1 - 1 of 1

Similar Datasets

2016-08-08 | E-GEOD-77212 | biostudies-arrayexpress
2014-04-04 | E-GEOD-51905 | biostudies-arrayexpress
2020-12-31 | GSE122151 | GEO
2014-04-04 | GSE51905 | GEO
2006-08-04 | GSE5441 | GEO
2012-12-01 | GSE33720 | GEO
2022-10-04 | GSE214501 | GEO
2017-04-27 | GSE98303 | GEO
2019-08-27 | GSE136278 | GEO
2019-08-27 | GSE136271 | GEO